Skip to content

Effect of the Antihistamine Injection to Prevent Paradoxical Reaction During Sedative Endoscopy

Effect of an Adjunctive Sedative for the Patients With Histories of Paradoxical Reaction to Midazolam During Sedative Endoscopy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03940391
Enrollment
220
Registered
2019-05-07
Start date
2019-05-01
Completion date
2020-04-14
Last updated
2020-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endoscopy

Keywords

paradoxical reaction, midazolam

Brief summary

This single-blind prospective study is aimed to investigate the effect of antihistamine as an adjunctive sedative for the patients with histories of severe paradoxical reaction to midazolam during sedative endoscopy. Participating patients are to receive antihistamine intravenously in addition to midazolam. The primary outcome is the reduction of paradoxical reaction in the antihistamine combination group. The secondary outcome is to compare sedation quality, performance quality, reduction of total midazolam dose will be analyzed between antihistamine combination and midazolam only group.

Detailed description

The present study will be conducted at Seoul National University Hospital Gangnam center between May 2019 and April 2020. Participants who have histories of paradoxical reaction to sedative endoscopy in medical record gave consent on the day of the endoscopy and were assigned to receive the combination of chlorpheniramine (4-6mg) with midazolam(1-10mg) Meanwhile, the patients do not want the use of chlorpheniramine and were assigned to midazolam alone as routine clinical practice. Research medication (chlorpheniramine) was administered 2 to 3 minutes before the administration of midazolam outside of endoscopy room. The blinded endoscopist and assistant nurse are going to perform induction for moderate sedation using incremental doses of the intravenous midazolam (1-2 mg) given every 2 minutes. The endoscopists and assistant nurses will assess the occurrence of severe paradoxical reaction (Grade 3) and other major quality outcomes (procedure/intubation time, sedation quality, completeness of procedure \[10 Key image documentation\], the satisfaction of procedure, side effects). The endoscopists and nurses will individually rate outcome measure using a 5-point Likert scale.

Interventions

DRUGChlorpheniramine and midazolam

Administration of chlorpheniramine injection as an adjunctive sedative during sedative endoscopy.

DRUGMidazolam

Administration of midazolam as a sedative during sedative endoscopy as routine clinical practice.

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
19 Years to 69 Years
Healthy volunteers
Yes

Inclusion criteria

* Previous histories of the paradoxical reaction during a sedative endoscopic examination

Exclusion criteria

* inability to execute informed consent * allergic to antihistamine agent * pregnancy * severe cardiopulmonary disease * prior administration of antihistamine on the same day

Design outcomes

Primary

MeasureTime frameDescription
Occurrence of severe paradoxical reaction (>= level 3)1 day(1) irrational talking or increased talkativeness such as mumbling to himself/herself; (2) restlessness or loss of cooperation such as resisting the insertion of endoscope or trying to bite the scope; (3) excessive movement requiring repositioning such as jerking or swinging movements of the arms and legs or trying to draw out the scope or mouthpiece; and (4) hostile action such as trying to strike the endoscopists or attending nurses.

Secondary

MeasureTime frameDescription
Dose of midazolam1 daytotal amount of benzodiazepine
completeness of procedure1 dayphoto documentation of key anatomical area
procedure/intubation time1 dayprocedural time (time from scope insertion to scope out) Intubation time (time from scope insertion to upper esophagus)
Satisfaction for the procedure1 day5-point Likert scale for pain and sedation: patients 1. Strongly unsatisfied 2. Unsatisfied 3. Neither satisfied nor unsatisfied 4. Satisfied 5. Strongly satisfied
adverse events1 dayhypoxia, arrythmia, low blood pressure and administration of antidote
Satisfaction for Quality of sedation1 day5-point Likert scale : endoscopists and assistant nurses 1. Strongly unsatisfied 2. Unsatisfied 3. Neither satisfied nor unsatisfied 4. Satisfied 5. Strongly satisfied

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026